Understanding and Actualizing DCTs, SDR and SOAR: Toward a New Paradigm for Research in a Changing World, Upcoming Webinar Hosted by Xtalks

Share Article

In this free webinar, the featured speakers will discuss the characteristics of decentralized clinical trials (DCTs) and hybrid trials and how these differ from virtual trials as well as a spectrum of approaches to DCTs, how they help patients, and the impact of the pandemic on the adoption of remote approaches. Attendees will learn about source data review (SDR) and how it aligns with risk-based monitoring and differs from source data verification (SDV) and how a systems approach to clinical research and standards can support DCTs.

Xtalks Logo

Xtalks Life Science Webinars

DCTs can be customized per protocol while leveraging technology and core processes that place more control closer to the source (i.e., the patient and their physician) such that they are mutually beneficial for sponsors, physicians, and especially their patients.

Decentralized clinical trials (DCTs), which were encouraged by the FDA as a means to modernize clinical trials per the 21st Century Cures Act, have received new interest during the pandemic. Consideration for safety of study participants and clinicians in this changing world demands a new paradigm for research.

DCTs (for which all trial activities are decentralized) or hybrid trials (which have a decentralized component) can be realized through a spectrum of approaches, which Parexel has been supporting in increasing numbers since the start of the pandemic. TransCelerate has defined and explored source data review (SDR) as a means of doing risk-based monitoring, including remote monitoring, with a focus on data integrity and data that are most critical and meaningful. Elligo‚Äôs System of Accelerated Research (SOAR®) takes a systems approach to clinical research. With SOAR, DCTs can more readily be actualized through technology-based services and a clinical control layer. DCTs can be customized per protocol while leveraging technology and core processes that place more control closer to the source (i.e., the patient and their physician) such that they are mutually beneficial for sponsors, physicians, and especially their patients.

Join Sy Pretorius, M.S., FFPM, EVP, Chief Medical & Scientific Officer, Parexel International, Mary Arnould, Director of Program Management and RBM Lead, Astellas US, LLC and Rebecca D. Kush, Ph.D., Chief Scientific Officer, Elligo Health Research in a live webinar on Tuesday, October 13, 2020 at 1pm EDT.

For more information or to register for this event, visit Understanding and Actualizing DCTs, SDR, and SOAR: Toward a New Paradigm for Research in a Changing World.

ABOUT XTALKS

Xtalks, powered by Honeycomb Worldwide Inc., is a leading provider of educational webinars to the global life science, food and medical device community. Every year thousands of industry practitioners (from life science, food and medical device companies, private & academic research institutions, healthcare centers, etc.) turn to Xtalks for access to quality content. Xtalks helps Life Science professionals stay current with industry developments, trends and regulations. Xtalks webinars also provide perspectives on key issues from top industry thought leaders and service providers.

To learn more about Xtalks visit http://xtalks.com
For information about hosting a webinar visit http://xtalks.com/why-host-a-webinar/

Share article on social media or email:

View article via:

Pdf Print

Contact Author

Sydney Perelmutter
Xtalks
+1 (416) 977-6555 x 352
Email >
Visit website